Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2024 08:00 ET | Source: Endomimetics, LLC

Endomimetics™ Awarded $300 Thousand Phase I SBIR Grant to Automate and Evaluate a Novel 3D in vitro model for use in Atherosclerosis drug Discovery and Development

Funding will support automation and large-scale fabrication of nanomatrix vascular sheet with atherosclerosis (VSA) functional assay plus its evaluation for use in drug efficacy and safety research ...
September 17, 2024 08:00 ET | Source: Endomimetics, LLC

Endomimetics™ Awarded $2.8 Million Phase II SBIR Grant to Develop and Evaluate the Potential of Bionanomatrix™ to Improve Performance and Patient Outcomes in the Treatment of Brain Aneurysms

BIRMINGHAM, Ala., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Endomimetics, the developer of Bionanomatrix™, a peptide-based biomaterial to promote healing and improve outcomes following medical device...
July 09, 2024 08:00 ET | Source: Endomimetics, LLC

Endomimetics™ Awarded $100,000 Grant from Innovate Alabama to Support Development and Evaluate Potential of Bionanomatrix™ to Reduce Infectious and Inflammatory Complications of Knee Arthroplasty

Grant supplements the $292 thousand one-year NIH/SBIR grant to develop this indication Knee arthroplasty is another example of the broad potential utility of Bionanomatrix™ to improve patient...
November 07, 2023 08:00 ET | Source: Endomimetics, LLC

Endomimetics™ Awarded $292 Thousand, One-Year NIH/SBIR Grant to Develop and Evaluate Potential of Bionanomatrix™ to Reduce Infectious and Inflammatory Complications of Knee Arthroplasty

BIRMINGHAM, Ala., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Endomimetics, the developer of BionanomatrixTM, a peptide-based biomaterial used to promote healing and improve outcomes following medical device...
February 14, 2023 08:00 ET | Source: Endomimetics, LLC

Endomimetics™ Announces a Research Collaboration Agreement with BISCO, Inc., to Support Development of a Dental Application of Bionanomatrix™

BIRMINGHAM, Ala., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Endomimetics, the developer of Bionanomatrix™, a peptide-based biomaterial to promote healing and improve outcomes following medical device...